Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» As CAR-T launch ramps up in U.S., Novartis' Narasimhan looks to convince Japan on performance-based pricing
As CAR-T launch ramps up in U.S., Novartis' Narasimhan looks to convince Japan on performance-based pricing
As CAR-T launch ramps up in U.S., Novartis' Narasimhan looks to convince Japan on performance-based pricing
Submitted by
admin
on October 5, 2017 - 6:16pm
Source:
Fierce Pharma
News Tags:
Novartis
CAR-T
Vas Narasimhan
Japan
drug pricing
performance-based pricing
Headline:
As CAR-T launch ramps up in U.S., Novartis' Narasimhan looks to convince Japan on performance-based pricing
Do Not Allow Advertisers to Use My Personal information
